Jiangsu Apon Medical Technology Co., Ltd. Share Price

Equities

300753

CNE100003FV4

Medical Equipment, Supplies & Distribution

End-of-day quote Shenzhen S.E. 03:30:00 26/04/2024 am IST 5-day change 1st Jan Change
11.8 CNY +1.29% Intraday chart for Jiangsu Apon Medical Technology Co., Ltd. +11.85% -31.28%

Financials

Sales 2022 324M 44.69M 3.73B Sales 2023 422M 58.26M 4.86B Capitalization 2.16B 299M 24.9B
Net income 2022 -76M -10.49M -875M Net income 2023 8M 1.1M 92.06M EV / Sales 2022 6.48 x
Net cash position 2022 181M 24.96M 2.08B Net cash position 2023 126M 17.46M 1.46B EV / Sales 2023 4.83 x
P/E ratio 2022
-29.8 x
P/E ratio 2023
261 x
Employees 670
Yield 2022 *
-
Yield 2023
-
Free-Float 51.92%
More Fundamentals * Assessed data
Dynamic Chart
Jiangsu Apon Medical Technology Co., Ltd. Proposes Final Dividend for 2023 CI
Jiangsu Apon Medical Technology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Jiangsu Apon Medical Technology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Jiangsu Apon Medical Technology Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023 CI
Jiangsu Apon Medical Technology Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023 CI
China and Hong Kong stocks close flat ahead of May manufacturing data RE
China, Hong Kong stocks fall ahead of May manufacturing data RE
Jiangsu Apon Medical Technology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Jiangsu Apon Medical Technology Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022 CI
Jiangsu Apon Medical Technology Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022 CI
Jiangsu Apon Medical Technology Co., Ltd. Approves Management Appointments CI
Jiangsu Apon Medical Technology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
Apon Medical Technology Forgoes 2021 Dividend as Full-Year Profit Tanks 44% MT
Jiangsu Apon Medical Technology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021 CI
Certain A-Shares of Jiangsu Apon Medical Technology Co., Ltd. are subject to a Lock-Up Agreement Ending on 13-DEC-2021. CI
More news
1 day+1.29%
1 week+11.85%
Current month-10.54%
1 month-6.79%
3 months-21.18%
6 months-31.79%
Current year-31.28%
More quotes
1 week
10.50
Extreme 10.5
12.41
1 month
9.71
Extreme 9.71
13.57
Current year
7.98
Extreme 7.98
17.87
1 year
7.98
Extreme 7.98
27.36
3 years
7.98
Extreme 7.98
27.36
5 years
7.98
Extreme 7.98
36.25
10 years
7.98
Extreme 7.98
36.25
More quotes
Managers TitleAgeSince
Chief Executive Officer 53 15/16/15
Director of Finance/CFO 47 15/16/15
Investor Relations Contact - -
Members of the board TitleAgeSince
Director/Board Member 52 05/22/05
Director/Board Member 55 01/16/01
Chairman 56 15/16/15
More insiders
Date Price Change Volume
26/24/26 11.8 +1.29% 7,261,399
25/24/25 11.65 +3.10% 3,699,979
24/24/24 11.3 +3.39% 3,898,809
23/24/23 10.93 +1.86% 5,029,350
22/24/22 10.73 +1.71% 4,453,702

End-of-day quote Shenzhen S.E., April 26, 2024

More quotes
Jiangsu Apon Medical Technology Co., Ltd. is a China-based company which is mainly engaged in research, development, production and sales of medical device products for pain management and nasal care. The Company's main products include medical devices such as micro-computer injection pumps, disposable drug injection pumps, wireless analgesia management systems, pulse oximeters and sensors for pain management, and nasal care applications such as nasal care sprayers. Among them, medical devices used in the field of pain management are mainly used for infusion and monitoring of drug treatment in postoperative, childbirth, cancer and other clinical treatments to alleviate pain in patients; medical devices used in nasal care are mainly used to relieve nasal dryness, nasal congestion and nose discomfort such as bleeding in patients. The Company operates primarily in domestic and overseas markets.
Calendar
More about the company
  1. Stock Market
  2. Equities
  3. 300753 Stock